We are live on ! Find out more
DRIO icon

DarioHealth

12 hedge funds and large institutions have $300K invested in DarioHealth in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

14% less funds holding

Funds holding: 1412 (-2)

32% less capital invested

Capital invested by funds: $442K → $300K (-$142K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

DRIO Hedge Fund Activity: Q1 2018 in Review

12 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2018, worth a combined $300K — down 32% from $442K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DRIO and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $30.5K. The largest seller was Anson Funds Management, exiting entirely with an estimated $168K sold.

  • 12 institutional investors held DarioHealth (DRIO) as of Q1 2018, down from 14 in Q4 2017.
  • Funds reported $300K of DarioHealth stock for Q1 2018, down 32% quarter-over-quarter.
  • 2 funds opened new DarioHealth positions in Q1 2018 and 4 closed out, a net change of -2 holders.
  • The largest DarioHealth buyer in Q1 2018 was Virtu Financial, an estimated $30.5K added.
  • The largest DarioHealth seller in Q1 2018 was Anson Funds Management, an estimated $168K sold.

Based on aggregated 13F filings for Q1 2018.